Activity ID



August 4, 2024

Format Type


CME Credit




CME Provider: JAMA Otolaryngology – Head & Neck Surgery

Description of CME Course

Olfactory dysfunction (OD) is one of the earliest and strongest predictors of COVID-19 infection, and thus is promising as a disease screening tool. Compared with objective testing, subjective olfactory assessments significantly underreport OD. Thus, an inexpensive, quick, and sensitive method of assessing olfaction may be beneficial for the early diagnosis and spread prevention of COVID-19. In this study, we evaluate the feasibility of a novel, objective olfactory test as part of an initial screening for COVID-19 in adults with unknown disease status.


1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.

Register for this Activity

ABMS Member Board Approvals by Type
More Information
Commercial Support?

NOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.

Educational Objectives

To identify the key insights or developments described in this article


Coronavirus (COVID-19)


Medical Knowledge

CME Credit Type

AMA PRA Category 1 Credit



View All Activities by this CME Provider

The information provided on this page is subject to change. Please refer to the CME Provider’s website to confirm the most current information.